Vir Biotechnology VIR
NASDAQ VIR
$13.15 -0.50 (-3.66%)
At close: Nov 10, 2026 · 4:00 PM EST

Vir Biotechnology (VIR) Shares Outstanding (2018 - 2026)

Updated

Vir Biotechnology's Weighted Average Shares Outstanding was 169.28 million in Q3 2026, up 21.8% from 138.93 million a year earlier and up 0.9% from the prior quarter.

Analysis

Vir Biotechnology (VIR) Shares Outstanding (2018 - 2026) Analysis & Trends

For FY2025, Weighted Average Shares Outstanding at Vir Biotechnology came in at 138.52 million, up 1.7% from FY2024.

  • Weighted Average Shares Outstanding has now increased for eight consecutive years, with a five-year compound annual growth rate of 3.1% (FY2020 to FY2025).
  • In earlier years, Weighted Average Shares Outstanding was 136.25 million in FY2024 (+1.6%), 134.13 million in FY2023 (+1.1%), 132.61 million in FY2022 (+2.1%) and 129.88 million in FY2021 (+9.0%).
  • The Q3 2026 figure marks the highest quarterly Weighted Average Shares Outstanding in data going back to Q3 2018.
  • Compared with a year earlier, Weighted Average Shares Outstanding has increased for 24 straight quarters, with growth averaging 7.3% over the last eight quarters.
  • Across the past five years, year-over-year growth in Weighted Average Shares Outstanding ran from 1.1% in Q1 2023 to 21.8% in Q3 2026.
  • Per Business Quant data, VIR's Weighted Average Shares Outstanding in the three quarters before Q3 2026 was 167.72 million (Q2 2026), 147.36 million (Q1 2026) and 138.52 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 891.90 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 2.41 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 1.77 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.94 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 1.55 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 541.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 1.24 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 5.70 Bn
10 Vir Biotechnology 2.28 Bn 363.84 Mn 188,000.00 169.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 169.28 Mn
Jun 30, 2026 167.72 Mn
Mar 31, 2026 147.36 Mn
Dec 31, 2025 138.52 Mn
Sep 30, 2025 138.93 Mn
Jun 30, 2025 138.45 Mn
Mar 31, 2025 137.47 Mn
Dec 31, 2024 136.25 Mn
Sep 30, 2024 136.65 Mn
Jun 30, 2024 136.23 Mn
Mar 31, 2024 135.28 Mn
Dec 31, 2023 134.13 Mn
Sep 30, 2023 134.29 Mn
Jun 30, 2023 134.06 Mn
Mar 31, 2023 133.55 Mn
Dec 31, 2022 132.61 Mn
Sep 30, 2022 132.73 Mn
Jun 30, 2022 132.45 Mn
Mar 31, 2022 132.08 Mn
Dec 31, 2021 129.88 Mn
API Access

Vir Biotechnology Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=VIR&period=max&api_key=YOUR_API_KEY